|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 60.01 INR | -0.07% |
|
-1.59% | -25.12% |
| Market Cap | 1.09B 11.49M 9.94M 9.28M 8.51M 16.01M 16.26M 109M 42.73M 548M 43.13M 42.19M 1.81B | P/E 2024 |
-12.2x | P/E 2025 | -28.6x |
|---|---|---|---|---|---|
| Enterprise Value | 1.17B 12.28M 10.62M 9.92M 9.1M 17.11M 17.38M 116M 45.67M 586M 46.11M 45.1M 1.94B | EV / Sales 2024 |
3.16x | EV / Sales 2025 | 3.93x |
| Free-Float |
44.12% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -0.07% | ||
| 1 week | -1.59% | ||
| Current month | -1.59% | ||
| 1 month | -17.83% | ||
| 3 months | +14.20% | ||
| 6 months | -1.51% | ||
| Current year | -25.12% |
| 1 week | 59.26 |  | 62.4 |
| 1 month | 57.5 | | 72.25 |
| Current year | 36.3 | | 82.44 |
| 1 year | 36.3 | | 164.02 |
| 3 years | 36.3 | | 198.86 |
| 5 years | 36.3 | | 198.86 |
| 10 years | 13.85 | | 198.86 |
| Manager | Title | Age | Since |
|---|---|---|---|
Prashant Rathi
CEO | Chief Executive Officer | - | 01/06/2026 |
Rajesh Mahajan
CEO | Chief Executive Officer | 58 | 23/01/2002 |
Atul Ranchal
PSD | President | 57 | 23/08/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 62 | 10/09/2010 | |
Lalit Mahajan
BRD | Director/Board Member | 60 | 13/09/2011 |
| Director/Board Member | 53 | 23/11/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.07% | -1.59% | -60.72% | -33.32% | 18.57M | |
| -0.31% | -2.29% | +21.68% | +67.56% | 49.03B | |
| +4.40% | +14.46% | +66.32% | +142.60% | 42.33B | |
| -0.89% | -0.64% | -1.82% | +19.63% | 12.43B | |
| +0.56% | -1.12% | +17.97% | +70.05% | 11.68B | |
| +0.19% | +0.77% | +31.08% | +139.91% | 9.12B | |
| +1.99% | +4.41% | +20.08% | +36.28% | 7.15B | |
| +1.82% | -0.15% | +39.86% | -12.61% | 7.09B | |
| +0.40% | +2.02% | +10.49% | +179.30% | 6.76B | |
| +6.44% | +8.26% | -24.87% | +30.54% | 5.95B | |
| Average | +1.45% | +2.30% | +12.01% | +63.99% | 15.16B | |
| Weighted average by Cap. | +1.56% | +3.75% | +30.94% | +87.42% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 795M 8.35M 7.22M 6.75M 6.19M 11.64M 11.83M 79.15M 31.07M 398M 31.36M 30.68M 1.32B | 826M 8.67M 7.5M 7.01M 6.43M 12.09M 12.28M 82.21M 32.27M 414M 32.57M 31.86M 1.37B |
| Net income | -196M -2.06M -1.78M -1.66M -1.53M -2.87M -2.91M -19.51M -7.66M -98.2M -7.73M -7.56M -325M | -99.67M -1.05M -906K -846K -776K -1.46M -1.48M -9.93M -3.9M -49.96M -3.93M -3.85M -165M |
| Net Debt | 55.16M 580K 501K 468K 430K 808K 821K 5.49M 2.16M 27.65M 2.18M 2.13M 91.41M | 75.39M 792K 685K 640K 587K 1.1M 1.12M 7.51M 2.95M 37.79M 2.97M 2.91M 125M |
Employees
323
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/08/26 | ₹60.01 | -0.07% | 14,886 |
| 06/08/26 | ₹60.05 | -0.40% | 27,618 |
| 05/08/26 | ₹60.29 | -0.82% | 30,001 |
| 04/08/26 | ₹60.79 | -0.77% | 12,417 |
| 03/08/26 | ₹61.26 | +0.46% | 8,073 |
- Stock Market
- Stocks
- BROOKS Stock
Select your edition
All financial news and data tailored to specific country editions
